Sort
15,842 grants matching “pancreatic cancer”
GPCRs: novel targets in cancer-associated fibroblasts
$168,563Paul A Insel · University Of California, San Diego · R21 · FY2015 · CA
A Creative Integration of Omega-3 Fatty Acids into Pancreatic Cancer Chemotherapy
$168,563Zhengrong Cui · University Of Texas At Austin · R21 · FY2015 · CA
Chemical ablation of ductal tree for breast cancer prevention
$168,563Lorenzo Sempere · Michigan State University · R21 · FY2020 · CA
Nanoparticle Enabled L-asparaginase Therapy for CLL
$168,563Sadik Esener · University Of California, San Diego · R21 · FY2013 · CA
Therapeutic Monitoring in Pancreatic Cancer Using an Exosome Based Mass Spec Assay
$168,563David M. Lubman · University Of Michigan At Ann Arbor · R21 · FY2016 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$168,482Farrokh Dehdashti · Washington University · R01 · FY2023 · CA
Clinical Studies of Circulating Epithelial Cancer Cells
$168,429Ccc Diagnostics, Llc · R44 · FY2004 · CA
ZINC FINGER GENES AND PANCREATIC CELL GROWTH
$168,247Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2000 · DK
Novel Mcl-1 inhibitors for Pancreatic Cancer Therapy
$168,205Zaneta Nikolovska-Coleska · University Of Michigan At Ann Arbor · R21 · FY2012 · CA
Imageable Mouse Models of Pancreatic Cancer
$168,152University Of California San Diego · R21 · FY2004 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$168,145Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Metabolic changes accompanying durable, hypoxia-driven EMT in pancreas cancer
$167,870Matthew J Lazzara · University Of Virginia · U01 · FY2023 · CA
A Novel ROS Controlling Kinase
$167,857Eileen Anne Friedman · Upstate Medical University · R21 · FY2011 · CA
Axl as a target for the therapy of pancreatic cancer
$167,726Rolf A Brekken · Ut Southwestern Medical Center · R21 · FY2014 · CA
Tissue Modeling and Drug Discovery Core
$167,708Hernan Alcides Flores-Rozas · Florida Agricultural And Mechanical Univ · U54 · FY2024 · CA
Optimizing selective in vivo inhibition of pancreatic tumor JAK2/STAT3 signaling
$167,613Mitch A Phelps · Ohio State University · R21 · FY2014 · CA
Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
$167,603Beverly A Guadagnolo · University Of Tx Md Anderson Can Ctr · R21 · FY2013 · CA
Discoidin Domain Receptors: Novel Players in Pancreatitis and Pancreatic Preneoplasia
$167,592Rafael A. Fridman · Wayne State University · R21 · FY2016 · CA
Validation of Amplified Genes in Pancreatic Cancer
$167,556Jeffrey M. Trent · Translational Genomics Research Inst · P01 · FY2006 · CA
Cancer Emulation Analysis with Deep Neural Network
$167,500Shuangge Ma · Yale University · R03 · FY2023 · CA
Autoimmunity to Protein Modifications in Checkpoint Inhibitor Induced and Spontaneous T1D
$167,500Mark J. Mamula · Yale University · R01 · FY2018 · DK
Pancreas cancer combination therapy based on stromal modulators and nano-carriers
$167,489Robert M Straubinger · State University Of New York At Buffalo · R21 · FY2013 · CA
Elucidating and targeting epigenetic oncogenic networks in pancreatic cancer
$167,480Alexandros Tzatsos · George Washington University · R21 · FY2014 · CA
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
$167,475Shaker A Mousa · Albany College Of Pharmacy · R21 · FY2008 · CA
NOVEL PAN-RALGEF INHIBITORS TO BLOCK PANCREATIC CANCER.
$167,475Geoffrey J. Clark · University Of Louisville · R21 · FY2018 · CA